Navigation Links
BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
Date:12/3/2013

Norwood, MA (PRWEB) December 03, 2013

On November 18, BioPharm Insight released its 3Q13 Licensing League Tables Report, reflecting an 18% decrease in pharmaceutical licensing by value since 2Q13. BioPharm Insight, part of Infinata, Inc., is a leading provider of business intelligence solutions and belongs to the Financial Times Group.

“BioPharm Insight subscribers have a distinct advantage with our quarterly Licensing League Tables,” said Ruth McHenry, Infinata’s managing director. “It fuels their ability to make strategic long-term decisions about the competitive drug development market, using critical information before it’s available anywhere else.”

The third quarter saw 120 agreements in the life sciences industry, with an aggregate disclosed value of $6.3 billion, a decrease from 2Q13, in which 121 agreements worth $7.6 billion were announced. The agreement between Ablynx and AbbVie, involving the drug ALX-0061, was the largest deal in 3Q13, potentially valued at $840 million.

Law firms Goodwin Procter and Duane Morris top the Global Licensing League Tables of Legal Advisors for the quarter. Based on information only available to editors at BioPharm Insight, Goodwin Procter tops the value table, having advised on three pharmaceutical drug licensing agreements, valued at $1.2 billion. Duane Morris leads the volume table with five transactions worth USD $933 million.

Download the full report here.

About BioPharm Insight
BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131

Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/12/prweb11383272.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
2. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
3. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
4. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
5. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
8. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
9. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
10. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
11. Biopharmaceuticals - A Global Market Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in ... and offered an opportunity to collaborate and network with healthcare colleagues across the United ... gathered for a lively discussion on trends and issues that healthcare leaders will face ...
(Date:3/28/2017)... ... ... that reveals the mystery of Kevin’s purpose. “A Prophets Bones” is the creation of published ... him that he had neglected to do, but this was from God and there was ... would have felt themselves to be special and better than others due to the fact ...
(Date:3/27/2017)... ... ... New patients who have sleep apnea in Aurora, CO, can now ... Sleep apnea is often left untreated because patients are not familiar with common symptoms ... , Dr. Braasch seeks to raise awareness of sleep apnea in Aurora, CO, and ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Bruce Trimble and Michelle ... requiring a referral. Trimble Dental offers a variety of services to meet each ... Whether patients have discolored, crooked or missing teeth in Eau Claire, WI, Drs. ...
(Date:3/27/2017)... ... ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and Bilal Chaudhry ... this treatment plays in protecting oral health, along with the benefits of receiving ... a root canal in White Plains, NY or their second location in Mt. Kisco, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ... workflow solutions and radiation therapy for the early ... PowerLook® Tomo Detection received Premarket Approval (PMA) from ... Tomo Detection is a first-of-its-kind, concurrent-read computer aided ... is the latest innovation available on the PowerLook® ...
(Date:3/27/2017)...  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its ... as Impax,s President and Chief Executive Officer and ... 2017. Mr. Bisaro will succeed J. Kevin Buchi ... Executive Officer since December of 2016. ... Mr. Bisaro, 56, is an accomplished global business leader ...
Breaking Medicine Technology: